Healthcare data breaches are becoming more frequent but smaller in scale, targeting smaller entities and high-value ...
Agenus Inc. , a leader in immuno-oncology innovation, today announced the publication of clinical results from the ovarian cancer cohort of its Phase 1b C-800-01 trial evaluating botensilimab plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback